Actinium Pharmaceuticals, Inc. (ATNM)
$1.00-5.66%Close
SELLCRISIS · day 6
Key stats
Short interest · FINRA settlement 2026-09-30
- Market cap
- $31M
- Beta
- 0.02
- P/E (TTM)
- 2.78
- Short % float
- 2.26%
- Days to cover
- 8.7
- SI change
- -0.3%
- 1W
- -9.91%
- 1M
- -21.88%
- vs SPY 1W
- -9.77%
- vs SPY 1M
- -24.38%
Prediction markets
Kalshi · Polymarket · … linked
Loading markets…
Company news
FAQ
- What is LOPJLB’s current signal on ATNM?
- LOPJLB’s latest quantitative signal on Actinium Pharmaceuticals, Inc. (ATNM) is SELL in a CRISIS regime. Signals are updated daily.
- What market regime is ATNM in?
- Actinium Pharmaceuticals, Inc. (ATNM) is currently classified in the CRISIS HMM market regime on LOPJLB.
- What does Actinium Pharmaceuticals, Inc. (ATNM) do?
- Actinium Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical firm dedicated to developing and commercializing treatments, primarily focusing on those for bone marrow transplant (BMT) or other cellular and adoptive cell therapies. Its leading drug candidate, I-131 apamistamab (known as Iomab-B), is currently in a crucial Phase III clinical trial for its role in conditioning elderly patie…